HEALTH RESULTS AFTER INFLIXIMAB PHARMACOKINETIC MONITORING IN INFLAMMATORY BOWEL DISEASE
5PSQ-121
FIDAXOMICIN RELATED METABOLIC ACIDOSIS: A CASE REPORT
5PSQ-120
USE OF PROTON PUMP INHIBITORS IN A GERIATRIC HEALTHCARE CENTRE
5PSQ-119
PROTON PUMP INHIBITOR PRESCRIPTION PATTERNS AND ASSOCIATED COMPLICATIONS IN THE PAEDIATRIC INTENSIVE CARE UNIT
5PSQ-028
PRESCRIPTION PROFILE OF ISAVUCONAZOLE IN THE REAL WORLD CLINICAL PRACTICE (submitted in 2019)
5PSQ-118
DESCRIPTIVE COMPARATIVE SAFETY ANALYSIS OF PALBOCICLIB AND RIBOCICLIB IN METASTATIC BREAST CANCER HER2 NEGATIVE WITH POSITIVE HORMONAL RECEPTORS (submitted in 2019)
5PSQ-117
ANALYSIS OF MEDICATION ERRORS AN ONCOLOGY SETTING USING AN INTERNAL REPORTING SYSTEMS (submitted in 2019)
5PSQ-116
SAFER HANDLING OF ORAL HAZARDOUS DRUGS IN HOSPITAL UNITS (submitted in 2019)
5PSQ-115
NEAR MISS DISPENSING ERRORS DURING WORKING HOURS IN INPATIENT DISPENSARIES AT A LARGE UK TEACHING HOSPITAL (submitted in 2019)
5PSQ-114
IMPROVING MEDICATION ADMINISTRATION FOR PATIENTS WITH DYSPHAGIA (submitted in 2019)
5PSQ-113
COMPATIBILITY AND STABILITY OF ONDANSETRON AND MIDAZOLAM MIXTURES USED IN PALLIATIVE CARE (submitted in 2019)
5PSQ-112
IMPACT OF HIGH TEMPERATURE AND SHAKING ON CHARGE VARIANTS OF ADALIMUMAB (HUMIRA) ASSESSED BY LIQUID CHROMATOGRAPHY COUPLED MASS SPECTROMETRY (submitted in 2019)
5PSQ-111
ADVERSE DRUG REACTIONS DUE TO MEDICINES UNDER ADDITIONAL MONITORING (submitted in 2019)
5PSQ-110
NUTRITIONAL ASSESSMENT IN A LONG TERM CARE FACILITY (submitted in 2019)
5PSQ-109
READMISSIONS OF OLDER PATIENTS PRESENTING TO HOSPITAL WITH A FALL (RELIEF): A SYSTEMATIC REVIEW (submitted in 2019)
